A woman in her 60s had been losing weight and had bowel symptoms when a gastroenterologist spotted a “pelvic mass” on her uterus, following a CT colonograp ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are ...

The FDA has granted fast track designation to INX-315 for the treatment of CCNE1-amplified, platinum-resistant/refractory ovarian cancer.

She was found to have advanced ovarian cancer and died some months later. Her family complained to the Health and Disability ...

Endometrial cancer is the most common gynecological cancer in highly-developed countries, most often affecting women after ...

It was during a dream solo three-month trip to the Bahamas in July 2022 that Louisa Lloyd realised something was seriously ...

Surgical Approach The latest advancement in the treatment of liver cancer is liquifying tumors with high-intensity ultrasound waves in a completely non-invasive fashion. The new approach provides ...

Up to 90% of colorectal cancers can be cured if caught early. Learn about screening options at Fred Hutch to protect your health.

Savannah Stuthers, 20, "nearly vomited" when she saw pictures of the teratoma, and she felt horrified to learn what was ...

Ovarian cysts are usually just a sign of ovulation, occur naturally and go away in a few months without needing any treatment ...

INX-315, a CDK2 inhibitor, received FDA fast track designation for patients with CCNE1-amplified platinum-resistant ovarian ...